New cancer drug Nexavar not for Indians but western patients who afford #Bayer

Funny how Indian media, quick to mourn the “environment for investment” after the Supreme Court judgment on generics last year seems unwilling for their investees to face the criticism for their views. Indian media seems to find it diffcult to report such “identity politics”. In a crass yet frank admission, Bayer CEO Marijn Dekkers said […]

Read More